BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35385029)

  • 1. Relapsing Polychondritis in a Patient with Ankylosing Spondylitis under Two Different Tumor Necrosis Factor Alpha Inhibitors Treatment.
    İçaçan OC; Yalçın Mutlu M; Yıldırım F; Bes C
    Clin Ter; 2022 Apr; 173(2):97-98. PubMed ID: 35385029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Case of Ankylosing Spondylitis Coexisting with Relapsing Polychondritis, Antiphospholipid Syndrome, and Myelodysplastic Syndrome.
    Park H; Gon Kim J; Kim WU
    Intern Med; 2022 Aug; 61(15):2367-2371. PubMed ID: 35022354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary manifestations of ankylosing spondylitis and relapsing polychondritis.
    Lee-Chiong TL
    Clin Chest Med; 1998 Dec; 19(4):747-57, ix. PubMed ID: 9917964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?
    Hernández MV; Ruiz-Esquide V; Gómez-Caballero ME; Gómez-Puerta JA; Cañete JD; Sanmartí R
    Rheumatology (Oxford); 2011 Aug; 50(8):1523-5. PubMed ID: 21593064
    [No Abstract]   [Full Text] [Related]  

  • 5. Thoracic Manifestations of Ankylosing Spondylitis, Inflammatory Bowel Disease, and Relapsing Polychondritis.
    Danve A
    Clin Chest Med; 2019 Sep; 40(3):599-608. PubMed ID: 31376894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFα inhibitor biosimilar associated with polychondritis. A case-based review.
    Venetsanopoulou AI; Voulgari PV; Drosos AA
    Rheumatol Int; 2023 Sep; 43(9):1751-1754. PubMed ID: 37316633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis: A systematic review.
    Biya J; Dury S; Perotin JM; Launois C; Dewolf M; Deslée G; Lebargy F
    Medicine (Baltimore); 2019 Nov; 98(44):e17768. PubMed ID: 31689839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsing polychondritis: state-of-the-art review with three case presentations.
    Grygiel-Górniak B; Tariq H; Mitchell J; Mohammed A; Samborski W
    Postgrad Med; 2021 Nov; 133(8):953-963. PubMed ID: 34533099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polychondritis in a Patient With Ankylosing Spondylitis on an Anti-TNF-α Biosimilar Agent.
    Duro T; Li S; Jose D; Khawar T
    J Clin Rheumatol; 2021 Dec; 27(8S):S656. PubMed ID: 35073638
    [No Abstract]   [Full Text] [Related]  

  • 10. The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
    Wroński J; Fiedor P
    J Clin Pharmacol; 2019 Apr; 59(4):445-462. PubMed ID: 30476367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of relapsing polychondritis and eosinophilic granulomatous with polyangiitis: A rare entity.
    Özgür DS; Akkuzu G; Yildirim F; Yalçin Mutlu M; Karaali Oğlu B; Erdoğan M; Bes C
    Clin Ter; 2022; 173(6):500-502. PubMed ID: 36373442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsing polychondritis in a patient with ankylosing spondylitis using etanercept.
    Azevedo VF; Galli NB; Kleinfelder AD; D'Ippolito JF; Gulin Tolentino A; Paiva E
    Case Rep Rheumatol; 2014; 2014():353782. PubMed ID: 25276463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis, spondyloarthropathies, and relapsing polychondritis.
    Ostrowski RA; Takagishi T; Robinson J
    Handb Clin Neurol; 2014; 119():449-61. PubMed ID: 24365312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapsing polychondritis: a rare disease of multisystem involvement.
    Paudyal BP; Karki A; Zimmerman M
    JNMA J Nepal Med Assoc; 2007; 46(166):81-3. PubMed ID: 18094743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing polychondritis with Castleman-like lymphadenopathy: a case report.
    Manganelli P; Quaini F; Olivetti G; Savini M; Pileri S
    Clin Rheumatol; 1997 Sep; 16(5):480-4. PubMed ID: 9348144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab.
    Lahmer T; Knopf A; Treiber M; Heemann U; Thuermel K
    Clin Rheumatol; 2010 Nov; 29(11):1331-4. PubMed ID: 20495939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsing polychondritis syndrome associated with pustular psoriasis, spondylitis and arthritis mutilans.
    Hager MH; Moore ME
    J Rheumatol; 1987 Feb; 14(1):162-4. PubMed ID: 3572919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsing polychondritis and ankylosing spondylitis in the same patient.
    Bahiri R; Bzami F; Benbouazza K; Saoud B; Hajjaj-Hassouni N
    Joint Bone Spine; 2006 Jul; 73(4):482-4. PubMed ID: 16725363
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited auricular relapsing polychondritis in a child treated successfully with infliximab.
    Alqanatish JT; Alfarhan BA; Qubaiban SM
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31126928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of relapsing polychondritis with circumferential bronchial wall thickening including the tracheomembranous area with tumor necrosis factor-α inhibitor.
    Maekawa M; Yoshimura M; Kadowaki M; Nakano M; Moriwaki A; Ueda H; Yoshizawa S
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):197-201. PubMed ID: 35078245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.